Inovalon Holdings Inc

Inovalon — FY2018 Earnings Presentation

33 slides from Inovalon's earnings presentation, Feb 20, 2019

  1. Slide 1: Fourth Quarter & Full Year 2018 Earnings Supplement

    Fourth Quarter & Full Year 2018 Earnings Supplement February 20, 2019

  2. Slide 2: Cautionary Note Regarding Forward-Looking Statements

    Cautionary Note Regarding Forward-Looking Statement Certain statements contained in this presentation constitute forward-looking statements within the meaning of, and are intended to be covered by the safe harbor provisions of, Section 27A of the Securities Act of 1933, as amended, and Section 21E o

  3. Slide 3: Contents

    Contents 1 Overview 2 2018 Q4 and FY Financial Results This presentation serves as a supplement to the Inovalon announcement on February 20, 2019 2019 Financial Guidance pertaining to fourth quarter (Q4) and full 3 year 2018 results and 2019 guidance. 4 Appendix 1: Reconciliations INOV Q4 & FY 2018

  4. Slide 4: The Inovalon ONE Platform

    Payers Pharma Devices Diagnostics The Inovalon ONE® Platform Inovalon is a vertically integrated leader in cloud-based enablement of data-driven healthcare. Inovalon provides cloud-based, real-time Massive Advanced Intervention Data connectivity, analytics, intervention, and Data Assets Analytics To

  5. Slide 5: Empowering Data-Driven Healthcare In Scale

    Empowering Data-Driven Healthcare In Scale The reach of Inovalon’s platform has grown to touch the vast majority of the United States, able to empower the market’s largest data-driven healthcare initiatives. 100s Health Plans, Providers, Life Sciences, Pharmacy, and Diagnostics Organizations 264M+ P

  6. Slide 6: MORE2 Registry Dataset Growth

    MORE2 Registry® 43 2 ® 42 MORE REGISTRY DATASET GROWTH Dataset 41 40 39 38 37 36 Expansion 35 34 33 32 Inovalon’s primary-source datasets continue to 31 Patient Count Medical Event Count 30 expand rapidly. As of Q4 2018, the MORE2 29 28 ® 27 270 Registry dataset contains more than 264 million 26 260

  7. Slide 7: Contents

    Contents 1 Overview 2 2018 Q4 and FY Financial Results This presentation serves as a supplement to the Inovalon announcement on February 20, 2019 2019 Financial Guidance pertaining to fourth quarter (Q4) and full 3 year 2018 results and 2019 guidance. 4 Appendix 1: Reconciliations INOV Q4 & FY 2018

  8. Slide 8: FY2018 Highlights

    FY2018 Highlights 2018 marked a bookend of a period of transformation in which the Company experienced meaningful, positive inflection. A multitude of dynamics have been navigated with Inovalon being increasingly recognized for meaningful market differentiation and leadership, high-value cloud-based

  9. Slide 9: Subscription-Based Progression

    Subscription-Based Progression Inovalon continues to transform its revenue stream to subscription-based platform offerings. In 2018, Inovalon generated 80% of revenues from subscription-based platform offerings as compared to 66% in 2017. $124.6 $527.7 ($40.8) ($5.5) $449.4 $437.3 $427.6 80% 53% 54%

  10. Slide 10: Adjacent Market Expansion

    Adjacent Market Expansion Demand for Inovalon’s cloud-based platforms and data-driven capabilities is driving expansion not only in the Company’s original area of focus, the payer landscape, but also in the pharmacy/life sciences and provider landscapes, resulting in greater diversification of reven

  11. Slide 11: ACV, TCV and Bookings

    ACV, TCV and Bookings Inovalon’s sales have significantly expanded and accelerated, supporting strong growth going forward. The Company started reporting its sales performance in 2018 by providing Annual Contract Value (ACV) data for new sales, a metric reflecting the sum of the first 12 months of r

  12. Slide 12: Strong Organic Growth Inflection

    Strong Organic Growth Inflection The combination of growing demand for the Company’s cloud-based platform capabilities and significant increases in the Company’s sophistication and scale of sales capabilities is resulting in strong year-over-year increases in contract signings. Annualized Contract V

  13. Slide 13: 4Q Adjusting for Non-Comparable G&A

    4Q 18 Adjusting for Non-Comparable G&A General and administrative expenses increased $6.4M in Q4 2018 as compared to Q4 2017. The increase was driven by $2.0M in non- comparable items that do not otherwise relate to Inovalon’s ongoing performance and $7.0M in acquired G&A associated with ABILITY Net

  14. Slide 14: FY 2019 Adjusting for Non-Comparable G&A

    FY 2019 Adjusting for Non-Comparable G&A General and administrative expenses increased $55.1M in 2018 as compared to 2017. The increase was driven by $23.3M in non-comparable items that do not otherwise relate to Inovalon’s ongoing performance and $30.4M in acquired G&A associated with ABILITY Netwo

  15. Slide 15: Contents

    Contents 1 Overview 2 2018 Q4 and FY Financial Results This presentation serves as a supplement to the Inovalon announcement on February 20, 2019 2019 Financial Guidance pertaining to fourth quarter (Q4) and full 3 year 2018 results and 2019 guidance. 4 Appendix 1: Reconciliations INOV Q4 & FY 2018

  16. Slide 16: Positive Annual Revenue Retention

    Positive Annual Revenue Retention After several years of revenue pressure from a year-to-year contraction in Annual Revenue Retention (referred to by the Company as client churn), the successful implementation of the highly differentiated Inovalon ONE® Platform capabilities in conjunction with stron

  17. Slide 17: Strong Transition to Positive Organic Revenue Growth

    Strong Transition to Positive Organic Revenue Growth With the transition of Annual Revenue Retention to a positive 103% in 2019, a resolution of previous headwinds, and business from Signed New Logos contributing 3% organically to growth in 2019, the Company is experiencing a 19% swing in organic re

  18. Slide 18: Strong Annual Recurring Revenue Base

    Strong Annual Recurring Revenue Base Over the past several years, Inovalon has been transitioning its customer base from legacy to subscription-based contracts. The combination of business already transitioned to subscription-based contracts and new subscription-based contracts already signed during

  19. Slide 19: Expanding Annual Revenue Coverage Visibility

    Expanding Annual Revenue Coverage Visibility The combination of steep increases in Annual Revenue Retention, strong Annualized Contract Value (ACV) signings, and a resulting strong expansion in Annual Recurring Revenue base from existing clients plus new logos has resulted in strong revenue growth w

  20. Slide 20: 2019 Revenue Guidance Bridge

    • Annual Revenue Retention expected to contribute ~3 points in 2019 • Already sold New Logo Sales expected to contribute ~3 points in 2019 2019 Revenue • ABILITY acquisition expected to contribute ~8 points of revenue growth in 2019 • New client sales already closed expected to contribute ~4 points

  21. Slide 21: 2019 Adjusted EBITDA Margin Bridge

    • The full gross margin benefit of an increasing mix of higher margin 2019 Adjusted Platform offerings, coupled with continued technology-enabled efficiencies and the ABILITY acquisition, are seen driving continued EBITDA Margin operating leverage improvement in 2019. Bridge ~290 Basis Point Year-to

  22. Slide 22: Strong Subscription-Based Platform Adoption

    Strong Subscription-Based Platform Adoption After several years of revenue pressures, the Company’s successful transition to subscription-based contracts, strong Annual Revenue Retention, and strong sales growth now provide significant Coverage and resulting revenue visibility of 96% of 2019 guidanc

  23. Slide 23: Revenue

    Revenue The following revenue guidance is being reaffirmed as of February 20, 2019. $637 - $657 2013 – 2019G $528 14% CAGR $449 $437 $428 $362 $296 2013 2014 2015 2016 2017 2018 2019G Note: CAGR calculations undertaken to the mid-point of 2019 Guidance. All numbers in millions. Graphic drawn at midp

  24. Slide 24: Adjusted EBITDA

    Adjusted EBITDA The following Adjusted EBITDA guidance is being reaffirmed as of February 20, 2019. $200 - $210 2013 – 2019G 19% CAGR $152 $152 $134 $109 $100 $72 37% 35% 32% 29% 24% 23% 24% 2013 2014 2015 2016 2017 2018 2019G % of Revenue Note: CAGR calculations undertaken to the mid-point of 2019

  25. Slide 25: Cash Flow From Operations

    Cash Flow From Operations The following Cash Flow from Operations guidance is being reaffirmed as of February 20, 2019. $130 - $145 2013 – 2019G CAGR $104 13% $98 $93 $86 $90 (GAAP)1 $66 $68 ~22% 22% 24% 22% 22% 19%1 ~20% 15% 2013 2014 2015 2016 2017 20181 2019G % of Revenue Note: CAGR calculations

  26. Slide 26: CAPEX Returning Towards Historical Levels

    CAPEX Returning Towards Historical Levels During the period Q3 2016 through Q1 2018, the Company elected to invest more than $40M into incremental development towards the launch of the Inovalon ONE® Platform. The period of this disproportional investment is now substantially complete and is increasi

  27. Slide 27: Financial Guidance Table

    Financial Guidance Table In the setting of a now predominantly subscription-based contract portfolio, significantly increased client Annual Revenue Retention performance, an expanded Annual Recurring Revenue base, and strong YTD sales ACV metrics, Inovalon has significant visibility into 2019, provi

  28. Slide 28: Q1 2019 Financial Guidance

    Q1 2019 Financial Guidance In the setting of a now predominantly subscription-based contract portfolio, significantly increased client Annual Revenue Retention performance, an expanded Annual Recurring Revenue base, and strong YTD sales ACV metrics, Inovalon has significant visibility into 2019, pro

  29. Slide 29: Contents

    Contents 1 Overview 2 2018 Q4 and FY Financial Results This presentation serves as a supplement to the Inovalon announcement on February 20, 2019 2019 Financial Guidance pertaining to fourth quarter (Q4) and full 3 year 2018 results and 2019 guidance. 4 Appendix 1: Reconciliations INOV Q4 & FY 2018

  30. Slide 30: Reconciliation of Forward-Looking Guidance Adjusted EBITDA

    Reconciliation of Forward-Looking Guidance Adjusted EBITDA Inovalon defines Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) as net income or loss calculated in accordance with GAAP, adjusted for the impact of depreciation and amortization, other expense, net

  31. Slide 31: Reconciliation of Forward-Looking Guidance Non-GAAP Net Income

    Reconciliation of Forward-Looking Guidance Non-GAAP Net Income Inovalon defines Non-GAAP net income as net income or loss calculated in accordance with GAAP, adjusted to exclude tax-affected stock-based compensation expense, acquisition costs, restructuring expense, amortization of acquired intangib

  32. Slide 32: Definitions

    Definitions 1 Annual Recurring Revenue is defined as subscription-based revenue from existing clients plus outstanding intra-year renewals valued at an amount agreed upon in principal. 2 Annual Revenue Retention is defined as the percentage of revenue from engagements with existing clients in the pr

  33. Slide 33: Healthcare Empowered

    Healthcare Empowered® © 2019 by Inovalon. All rights reserved.

Inovalon Holdings — FY2018 Earnings Presentation on 6ix